0001171843-24-005512.txt : 20241004 0001171843-24-005512.hdr.sgml : 20241004 20241004161531 ACCESSION NUMBER: 0001171843-24-005512 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241004 FILED AS OF DATE: 20241004 DATE AS OF CHANGE: 20241004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PORTAGE BIOTECH INC. CENTRAL INDEX KEY: 0001095435 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40086 FILM NUMBER: 241355103 BUSINESS ADDRESS: STREET 1: CLARENCE THOMAS BUILDING STREET 2: P.O. BOX 4649, ROAD TOWN CITY: TORTOLA STATE: D8 ZIP: VG1110 BUSINESS PHONE: 416-737-7600 MAIL ADDRESS: STREET 1: CLARENCE THOMAS BUILDING STREET 2: P.O. BOX 4649, ROAD TOWN CITY: TORTOLA STATE: D8 ZIP: VG1110 FORMER COMPANY: FORMER CONFORMED NAME: BONTAN CORP INC DATE OF NAME CHANGE: 20030421 FORMER COMPANY: FORMER CONFORMED NAME: DEALCHECK COM INC DATE OF NAME CHANGE: 19990921 6-K 1 f6k_100424.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2024

Commission File Number: 001-40086

Portage Biotech Inc.

(Translation of registrant’s name into English)

Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

☒ Form 20-F

☐ Form 40-F

INCORPORATION BY REFERENCE

This report on Form 6-K (including any exhibits attached hereto) shall be deemed to be incorporated by reference into the registration statement on Form S-8 (File No. 333-275842) of Portage Biotech Inc. (including any prospectuses forming a part of such registration statement) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Management Changes

On September 30, 2024, Allan Shaw, Chief Financial Officer of Portage Biotech Inc. (the “Company”), and Joseph Ciavarella, accounting consultant to the Company, departed from the Company.

On September 30, 2024, Andrea Park, as Chief Financial Officer, and Adam Melero, as Controller, joined the Company.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 4, 2024

PORTAGE BIOTECH INC.

By:	/s/ Andrea Park
	Andrea Park
	Chief Financial Officer